Related Experiment Videos
The origin and function of soluble CD14 in experimental bacterial meningitis
1Division of Infectious Diseases, Department of Research, University Hospitals, Basel, Switzerland.
Journal of Immunology (Baltimore, Md. : 1950)
|April 14, 1999
Summary
Soluble CD14 (sCD14) is significantly elevated in cerebrospinal fluid during bacterial meningitis, originating from intrathecal leukocytes. This sCD14 acts as an inflammatory co-ligand, contributing to disease pathogenesis.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Bacterial meningitis is a severe central nervous system infection.
- The role of soluble CD14 (sCD14) in meningitis pathogenesis is not well understood.
- CD14 is a key receptor involved in innate immune responses to bacterial components.
Purpose of the Study:
- To investigate the origin and function of sCD14 in the brain during experimental bacterial meningitis.
- To determine whether sCD14 contributes to the inflammatory response in meningitis.
Main Methods:
- Murine models of bacterial meningitis using Escherichia coli LPS, Streptococcus pneumoniae, and Listeria monocytogenes.
- Measurement of sCD14 levels in serum and cerebrospinal fluid (CSF).
- Analysis of CD14 transcription and expression in leukocytes, astrocytes, and microglial cells using RT-PCR, FACS, in situ hybridization, and immunohistochemistry.
- Intracerebral inoculation of recombinant sCD14 (rsCD14) and S. pneumoniae to assess cytokine response.
Main Results:
- Dramatically elevated sCD14 concentrations were detected in CSF, with only minor increases in serum.
- Leukocytes invading the subarachnoid space showed active CD14 transcription and surface expression.
- Parenchymal astrocytes and microglial cells did not significantly contribute to elevated sCD14 levels.
- Simultaneous intracerebral inoculation of rsCD14 and S. pneumoniae resulted in a markedly increased local cytokine response.
Conclusions:
- Intrathecal leukocytes are the primary source of elevated sCD14 in the CSF during bacterial meningitis.
- sCD14 acts as an inflammatory co-ligand in vivo, playing a role in meningitis pathogenesis.
- These findings highlight sCD14 as a potential therapeutic target in bacterial meningitis.